Transmyocardial laser treatment a new treatment modality for patients with angina pectoris?;Transmyokardial laserbehandling - Et nytt tilbud ved uttalt angina pectoris?

Tidsskrift for den Norske Laegeforening

Volumn 119, Issue 24, 1999, Pages 3597-3601

  Tjomsland, Ole ^a   Almdahl, Sven M ^a   Saatvedt, Kjell ^a   Nordstrand, Kenneth ^a   Aaberge, Lars ^b  

^a Feiringklinikken   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANGINA PECTORIS; ANIMAL; HEART MUSCLE REVASCULARIZATION; HUMAN; LASER SURGERY; METHODOLOGY; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

ANGINA PECTORIS; ANIMALS; HUMANS; LASER SURGERY; MYOCARDIAL REVASCULARIZATION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0033543876     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Mirhoseini M, Cayton MM. Revascularization of the heart by laser. J Microsurg 1981; 2: 253-60.
2. Pratt FH. The nutrition of the heart through the vessels of Thebesius and the coronary veins. Am J Physiol 1898; 1: 86-103.
3. Wearns J, Klump TC, Zschiesche AB. The nature of the vascular communications between the coronary arteries and the chambers of heart. Am Heart J 1933; 9: 143-70.
4. Abramov D, Bhatnagar G, Tamariz M, Guru V, Goldman BS. Current status of transmyocardial laser revascularization: review of the literature. Can J Cardiol 1999; 15: 303-10.
5. Sen PK, Udwadia TE, Kinare SG, Parulkar GB. Transmyocardial revascularization: a new approach to myocardial revascularization. J Thorac Cardiovasc Surg 1965; 50: 181-9.
6. Hardy RI, Bove KE, James FW, Kaplan S, Goldman L. A histologic study of laser-induced transmyocardial channels. Lasers Surg Med 1987; 6: 563-73.
7. Frazier OH, Cooley DA, Kadipasaoglu KA, Pehlivanoglu S, Lindenmeir M, Barasch E et al. Myocardial revascularization with laser. Preliminary findings. Circulation 1995; 92: II58 -65.
8. The Criteria Committee of the New York Heart Association. Diseases of the heart and blood vessels: nomenclature and criteria for diagnosis. 6. utg. Boston: Little, Brown, 1964.
9. Kim CB, Kesten R, Javier M, Hayase M, Walton AS, Billingham ME et al. Percutaneous method of laser transmyocardial revascularization. Cathet Cardiovasc Diagn 1997; 40: 223-8.
10. 2 and holmium: YAG lasers. Ann Thorac Surg 1997; 64: 466-72.
11. Horvath KA, Smith WJ, Laurence RG, Schoen FJ, Appleyard RF, Cohn LH. Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization. J Am Coll Cardiol 1995; 25: 258-63.
12. Yano OJ, Bielefeld MR, Jeevanandam V, Treat MR, Marboe CC, Spotnitz HM et al. Prevention of acute regional ischemia with endocardial laser channels. Ann Thorac Surg 1993; 56: 46-53.
13. Kohmoto T, Fisher PE, Gu A, Zhu SM, Yano OJ, Spotnitz HM et al. Does blood flow through holmium-YAG transmyocardial laser channels? Ann Thorac Surg 1996; 61: 861-8.
14. Spanier T, Smith CR, Burkhoff D. Angiogenesis: a possible mechanism underlying the clinical benefits of transmyocardial laser revascularization. J Clin Laser Med Surg 1997; 15: 269-73.
15. Yamamoto N, Kohmoto T, Gu A, DcRosa C, Smith CR, Burkhoff D. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization. J Am Coll Cardiol 1998; 31: 1426-33.
16. Mirhoseini M, Muckerheide M, Cayton MM. Transventricular revascularization by laser. Lasers Surg Med 1982; 2: 187-98.
17. Tjomsland O, Grund F, Kanellopoulos GK, Kvernebo K, Ilebekk A. Transmyocardial laser induces coronary hyperemia and reduces ischemia-related arrhythmias, but fails to delay development of myocardial necrosis after coronary artery occlusion in pigs. J Cardiovasc Surg 1999; 40: 325-31
18. Kwong KF, Kanellopoulos GK, Nickols JC, Pogwizd SM, Saffitz JE, Schuessler RB et al. Transmyocardial laser treatment denervates canine myocardium. J Thorac Cardiovasc Surg 1997; 114: 883-9.
19. Cinca J, Bardaji A, Salas-Caudevilla A. Ventricular arrhythmias and local electrograms after chronic regional denervation of the ischemic area in the pig heart. J Am Coll Cardiol 1989; 14: 225-32.
20. Whittaker P, Rakusan K, Kloner RA. Transmural channels can protect ischemic tissue. Circulation 1996; 96: 143-51.
21. Roethy W, Yamamoto N, Burkhoff D. An examination of potential mechanisms underlying transmyocardial laser revascularization induced increases in myocardial blood flow. Semin Thorac Cardiovasc Surg 1999; 11: 24 -8.
22. 2-laser. Eur J Cardiothorac Surg 1997; 12: 25-30.
23. 2 laser-induced intramyocardial revascularization. Basic Res Cardiol 1990; 85: 179-97.
24. Mack CA, Patel SR, Rosengart TK. Myocardial angiogenesis as a possible mechanism for TMLR efficacy. J Clin Laser Med Surg 1997; 15: 275-9.
25. Kwong KF, Schuessler RB, Kanellopoulos GK, Saffitz JE, Sundt TM. Nontransmural laser treatment incompletely denervates canine myocardium. Circulation 1998; 98: II67-71.
26. Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nat Med 1997; 3: 158-64.
27. McFadden PM, Robbins RJ, Ochsner JL, Van Meter CH, Majorie S. Transmyocardial revascularization for cardiac transplantation allograft vasculopathy. J Thorac Cardiovasc Surg 1998; 115: 1385-8.
28. Glover RP, Davila JC, Kyle RH, Beard JC, Trout RG, Kitchell JR. Ligation of the internal mammary arteries as a means of increasing blood supply to the myocardium. J Thorac Cardiovasc Surg 1957; 34: 661-78.
29. Kim CB, Oesterle SN. Percutaneous transmyocardial revascularization. J Clin Laser Med Surg 1997; 15: 293-8.
30. Mirhoseini M, Fisher JC, Cayton MM. Myocardial revaseularization by laser: a clinical report. Lasers Surg Med 1983; 3: 241-5.
31. Campeau L. Grading of angina pectoris. Circulation 1976; 54: 522.
32. Bums SM, Sharples LD, Tait S, Caine N, Wallwork J, Schofield PM. The transmyocardial laser revascularization international registry report. Eur Mean J 1999; 20: 31-7.
33. 2 laser. I Clin Laser Med Surg 1997; 15: 281-5.
34. Schofield PM, Sharples LD, Caine N, Burns S, Tait S, Wistow T et al. Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet 1999; 353: 519-24.
35. 2 laser: one year results of a randomized, controlled trial. Semin Thorac Cardiovasc Surg 1999; 11: 12-8.
36. Trehan N, Mishra M, Bapna R, Mishra A, Maheshwari P, Karlekar A. Transmyocardial laser revascularisation combined with coronary artery bypass grafting without cardiopulmonary bypass. Eur J Cardiothorac Surg 1997; 12: 276-84.
37. Dowling RD, Petracek MR, Selinger SL, Allen KB. Transmyocardial revascularization in patients with refractory, unstable angina. Circulation 1999; 98: II73-6.
38. Cooley DA, Frazier OH, Kadipasaoglu KA, Lindenmeir MH, Pehlivanoglu S, Kolff JW et al. Transmyocardial laser revascularization: clinical experience with twelve-month follow-up. J Thorac Cardiovasc Surg 1996; 111: 791-7.
39. Horvath KA, Cohn LH, Cooley DA, Crew JR, Frazier OH, Griffith BP et al. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg 1997; 113: 645-53.
40. Nagele H, Stubbe HM, Nienaber C, Rodiger W. Results of transmyocardial laser revascularization in non-revascularizable coronary artery disease after 3 years follow-up. Eur Heart J 1998; 19: 1525-30.
41. 2 laser revascularisation: a chance for the «inoperable» patient. Eur J Cardiothorac Surg 1997; 11: 888-94.
42. Agarwal R, Ajit M, Kurian VM, Rajan S, Arumugam SB, Cherian KM. Transmyocardial laser revascularization: early results and 1-year follow-up. Ann Thorac Surg 1999; 67: 432-6.
43. Donovan CL, Landolfo KP, Lowe JE, Clements F, Coleman RB, Ryan T. Improvement in induciblc ischemia during dobutamine stress echocardiography after transmyocardial laser revascularization in patients with refractory angina pectoris. J Am Coll Cardiol 1997; 30: 607-12.
44. Aaberge L, Nordstrand K, Saatvedt K, Dragsund M, Forfang K. The Norwegian prospective randomised trial on transmyocardial revascularisation versus optimal medical treatment in patients with refractory angina: preliminary clinical results. Eur Heart J 1998; 19: 262.
45. Tjomsland O, Aaberge L, Almdahl SM, Dragsund M, Moelstad P, Saatvedt K et al. Periopcrative cardiac function and predictors for adverse events after transmyocardial laser treatment. Ann Thorac Surg 1999; akseptert for publisering.
46. Hughes GC, Landolfo KP, Lowry E, Coleman RB, Donovan CL. Perioperative morbidity and mortality after transmyocardial laser revascularization: incidence and risk factors for adverse events. J Am Coll Cardiol 1999; 33: 1021-6.
47. Horvath KA, Mannting F, Cummings N, Shernan SK, Cohn LH. Transmyocardial laser revascularization: operative techniques and clinical results at two years. J Thorac Cardiovasc Surg 1996; 111: 1047-5
48. Bhargava B, Kornowski R, Kent KM, Leon MB. Current status of percutaneous transmyocardial revascularisation. Indian Heart J 1998; 50: 130-7.
49. Sjoland H, Wiklund I, Caidahl K, Albertsson P. Herlitz J. Relationship between quality of life and exercise test findings after coronary artery bypass surgery. Int J Cardiol 1995; 51: 221-32.